# Decision-Making Approaches Used to Limit Potentially Nonbeneficial Life-Prolonging Interventions

**Authors:** Jason N. Batten, Sofia Weiss Goitiandia, Julia K. Axelrod, Helen O. Chernicoff, Ariadne A. Nichol, Lorraine M. Pereira, Jacob A. Blythe, Jacqueline M. Kruser, Elizabeth W. Dzeng

PMC · DOI: 10.1001/jamanetworkopen.2025.60260 · 2026-02-20

## TL;DR

This study explores how clinicians decide to avoid unnecessary life-prolonging treatments, finding that they often use methods not recommended by professional guidelines.

## Contribution

The study reveals that clinicians frequently use alternative decision-making approaches not aligned with professional policy recommendations.

## Key findings

- Clinicians reported using alternate approaches like explicitly not offering interventions or not mentioning them.
- Recommended approaches like shared decision-making and institutional processes faced significant challenges.
- There was variation in practice and uncertainty about ethical and practical decisions.

## Abstract

What decision-making approaches do clinicians use to limit potentially nonbeneficial life-prolonging interventions?

In this qualitative study of 101 clinician interviews conducted at 3 academic medical centers, respondents reported facing challenges limiting interventions using the approaches recommended in professional society policy statements (ie, shared decision-making, institutional processes addressing disagreement with patients or surrogates). Respondents described alternate approaches (eg, stating a plan to limit interventions, explicitly not offering interventions, not mentioning interventions) in which clinicians limited interventions without a shared decision or institutional process.

Clinicians face challenges in limiting potentially nonbeneficial life-prolonging interventions via recommended approaches, which may lead them to resort to alternate approaches.

This qualitative study describes the types of decision-making approaches clinicians reported using to limit the use of potentially nonbenefical life-prolonging interventions.

Professional society policy statements recommend that clinicians limit (ie, withhold or withdraw) potentially nonbeneficial life-prolonging interventions by (1) achieving a shared decision with patients or surrogates or (2) initiating an institutional process to address disagreement with patients or surrogates. However, in the context of a health care system with a default tendency toward life prolongation, it is unclear whether clinicians rely entirely on these recommended approaches or resort to alternate approaches.

To characterize the range of decision-making approaches clinicians report using to limit potentially nonbeneficial life-prolonging interventions.

This qualitative study was conducted at 3 tertiary academic medical centers in Washington and California. Clinicians were sampled from emergency department, medical ward, medical intensive care unit, geriatrics, and palliative care services between February 2018 and June 2022 for in-depth, semistructured interviews. Results were analyzed between August 2023 and May 2025.

After qualitatively analyzing interviews to identify decision-making approaches, we developed a framework of approaches that categorized each as a recommended or alternate approach.

We conducted 101 interviews (53 attending physicians [52%], 16 trainee physicians [16%], 6 advanced practice clinicians [6%], 21 nurses [21%], 3 chaplains [3%], and 2 social workers [2%]; 59 women [58%], 42 men [42%]; mean age, 42 years [range, 27-74 years]; mean years of experience, 14 [range, 1-52]). We identified 6 decision-making approaches: (1) providing an informed choice regarding interventions, (2) making a recommendation to limit interventions, (3) stating a plan to limit interventions, (4) explicitly not offering interventions, and (5) not mentioning interventions. In rare cases of intractable conflict, clinicians reported using an option of last resort: (6) invoking an institutional process to limit interventions. Respondents reported challenges with limiting interventions via the recommended approaches of shared decision-making (approaches 1-3) and institutional processes (approach 6), which sometimes discouraged the use of these approaches. While respondents recounted successfully using alternate approaches (approaches 3-5), they described interclinician and interhospital practice variation, as well as ethical and practical uncertainties.

In this qualitative study, clinicians reported substantial challenges using recommended approaches to limit potentially nonbeneficial life-prolonging interventions. Some clinicians reported using alternate approaches that are not supported in professional society policy statements.

## Full-text entities

- **Diseases:** pain (MESH:D010146), burnout (MESH:D002055), critical illness (MESH:D016638), toxicity (MESH:D064420), APC (MESH:D011125), myocardial infarction (MESH:D009203), COVID-19 (MESH:D000086382), pneumonia (MESH:D011014), life prolongation (MESH:D008133)
- **Chemicals:** Zosyn (MESH:D000077725)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12924098/full.md

---
Source: https://tomesphere.com/paper/PMC12924098